Acrivon Therapeutics, Inc. Common Stock (ACRV) ownership: Top institutional holder: RA CAPITAL MANAGEMENT, L.P. ($11.59M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 8340508.00 | $11.59M | 2026-03-31 |
| CITADEL ADVISORS LLC | 1641884.00 | $3.96M | 2025-12-31 |
| Sands Capital Alternatives, LLC | 2122605.00 | $2.95M | 2026-03-31 |
| VANGUARD GROUP INC | 698857.00 | $1.68M | 2025-12-31 |
| WELLINGTON MANAGEMENT GROUP LLP | 888130.00 | $1.23M | 2026-03-31 |
| ACADIAN ASSET MANAGEMENT LLC | 845973.00 | $1.18M | 2026-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 758440.00 | $1.05M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 722035.00 | $1.00M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-05-21 | |
| Sell | null | 2026-05-18 | |
| Sell | null | 2026-05-18 | |
| Sell | null | 2026-05-18 | |
| Sell | null | 2026-05-18 | |
| Sell | null | 2026-05-18 | |
| Sell | null | 2026-05-18 | |
| Sell | null | 2026-05-18 |
Back to ACRV overview · ACRV earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.